Has Ye Olivia Xu-Cai received payments from drug or device companies?

Yes. Drug and device makers reported $7,361 in general payments to Ye Olivia Xu-Cai across 401 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ye Olivia Xu-Cai did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ye Olivia Xu-Cai come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ye Olivia Xu-Cai

Internal Medicine · Tulsa, OKNPI 1457314635

Payments from drug & device makers

$7,361in general payments, 2019–2025

Across 401 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$817
GSK$756
Boehringer Ingelheim$721
Lilly USA, LLC$581
AstraZeneca$558
Novo Nordisk$479
plus $3K from 36 others

What the payments were for

Food & beverage$7,28699%
Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	46	$817
GSK	46	$756
Boehringer Ingelheim	37	$721
Lilly USA, LLC	35	$581
AstraZeneca(2 entities)	21	$558
Novo Nordisk	25	$479
Johnson & Johnson	27	$448
Amgen	18	$374
Amarin Pharma, Inc.	13	$211
Merck	13	$200
Bayer	11	$193
Astellas Pharma US Inc	6	$171
Novartis	11	$166
Abbott	4	$162
Sanofi-aventis U.S. LLC	7	$141
Takeda Pharmaceuticals U.S.A., Inc.	8	$133
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$116
Lundbeck LLC	5	$105
Otsuka America Pharmaceutical, Inc.	4	$80
Arbor Pharmaceuticals, Inc.	4	$75
Biohaven Pharmaceutical Holding Company Ltd.	4	$74
Eisai Inc.	5	$73
Pfizer	4	$67
Almatica Pharma LLC	4	$65
E.r. Squibb & Sons, L.L.C.	4	$63
Kowa Pharmaceuticals America, Inc.	4	$60
Axsome Therapeutics, Inc.	2	$57
Paratek Pharmaceuticals, Inc.	3	$50
Esperion Therapeutics, Inc.	3	$47
Jazz Pharmaceuticals Inc.	3	$40
Endo Pharmaceuticals Inc.	2	$39
Corium, LLC	2	$38
Baxter Healthcare	2	$34
Idorsia Pharmaceuticals US Inc	2	$27
Biogen	1	$23
Advanced Respiratory, Inc	1	$22
Mylan Specialty L.p.	1	$20
Sanofi Pasteur Inc.	1	$19
Althera Pharmaceuticals LLC	1	$16
Genentech USA, Inc.	1	$15
Therapeuticsmd, Inc.	1	$14
Biohaven Pharmaceuticals, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,361 in reported general payments places this provider in the 90th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	19	$455
Amlodipine Besylate	15	$117

Paid to pharmacies, not to this prescriber.

Other internal medicine in Tulsa

Al-Ola AbdallahTulsa$10.1M
Melita TateTulsa$9.1M
Renae MayerTulsa$766K
Mousumi SomTulsa$391K
Jesse RichardsTulsa$279K
Madhuri LadTulsa$195K
Lam leTulsa$191K
Stacy ChronisterTulsa$163K
Katherine CookTulsa$41K
Layth Al AttarTulsa$35K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →